IRIS
TERRANOVA, NADIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 697
EU - Europa 472
AS - Asia 364
Continente sconosciuto - Info sul continente non disponibili 4
AF - Africa 2
OC - Oceania 1
SA - Sud America 1
Totale 1.541
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 689
CN - Cina 349
IE - Irlanda 184
UA - Ucraina 80
DE - Germania 52
FI - Finlandia 49
SE - Svezia 42
IT - Italia 23
GB - Regno Unito 17
BE - Belgio 15
CA - Canada 8
SG - Singapore 6
FR - Francia 5
EU - Europa 4
GR - Grecia 4
KR - Corea 3
IL - Israele 2
JP - Giappone 2
MU - Mauritius 2
AU - Australia 1
BO - Bolivia 1
IN - India 1
KZ - Kazakistan 1
NL - Olanda 1
Totale 1.541
Salva come PNG Salva come JPEG
Città #
Dublin 182
Chandler 166
Jacksonville 113
Nanjing 93
Ann Arbor 52
Beijing 52
Boardman 49
Nanchang 41
Ashburn 29
Hebei 29
Princeton 26
Lawrence 25
Medford 25
Wilmington 24
Changsha 22
Shenyang 21
Jiaxing 20
Tianjin 19
Dearborn 18
New York 18
Shanghai 18
Hangzhou 16
Brussels 15
Helsinki 8
Pavia 8
Woodbridge 8
Toronto 7
Singapore 5
Kunming 4
Los Angeles 4
Milan 4
Norwalk 4
Fairfield 3
Ningbo 3
Piscataway 3
Washington 3
Hefei 2
Houston 2
Netanya 2
Saronno 2
Tokyo 2
Zhengzhou 2
Amsterdam 1
Carate Brianza 1
Cincinnati 1
Des Moines 1
Fuzhou 1
Grugliasco 1
Guangzhou 1
Gunzenhausen 1
Hyderabad 1
Lanzhou 1
Las Vegas 1
Lodi Vecchio 1
Orange 1
Redwood City 1
Santa Clara 1
Seattle 1
Secaucus 1
Sucre 1
Sydney 1
Taizhou 1
Verona 1
Totale 1.170
Salva come PNG Salva come JPEG
Nome #
A non parametric population approach for selecting biomarkers of a drug action 97
A mathematical model for assessing the glucose time course in critically ill patients 89
An energy based model able to describe the effect of anticancer drugs on tumor growth and host body weight 87
A data mining approach to evaluate the performance of recruitment centres in antidepressant drug clinical trials 84
A PK-PD model of tumor growth after administration of an anti-angiogenic agent given alone or in combination therapies in xenograft mice 82
A predictive pharmacokinetic-pharmacodynamic model of tumor growth kinetics in xenograft mice after administration of anticancer agents given in combination 76
A new population PK/PD model to assess the myelotoxicity of candidate drugs in preclinical and in clinical studies 75
Mathematical models of tumor growth inhibition in xenograft mice after administration of anticancer agents given in combination 72
Study of energetic interactions between the tumor and host to assess the efficacy of an anticancer drug: a new mathematical model 70
A Minimal Model of Tumor Growth Inhibition in Combination Regimens under the Hypothesis of no Interaction between Drugs 69
A tumor growth inhibition model in drugs combination regimens 68
Modelling of protozoa dynamics and drug effects in a murine model of malaria infection 64
Mouse embryonic stem cells that survive γ-rays exposure maintain pluripotent differentiation potential and genome stability. 63
Landscape on technical and conceptual requirements in Drug/Disease Modelling & Simulation 60
Modeling tumor growth inhibition and toxicity outcome after administration of anticancer agents in xenograft mice: A Dynamic Energy Budget (DEB) approach 58
Mathematical modeling of growth and death dynamics of mouse embryonic stem cells irradiated with gamma-rays 55
Assessing the glucose time course in critically ill patients by a mathematical model 55
TGI-Simulator: A visual tool to support the preclinical phase of the drug discovery process by assessing in silico the effect of an anticancer drug 51
Evaluation of a PK/PD DEB-based model for tumor-in-host growth kinetics under anticancer treatment 48
Evaluation of a tumor growth inhibition (TGI) model integrating dynamic energy budget (DEB) theory 46
Model Description Language (MDL) - a standard for model communication and interoperability 44
Model description language (MDL): a standard for pharmacometric modelling and simulation 42
White Paper: Landscape on Technical and Conceptual Requirements and Competence Framework in Drug/Disease Modeling and Simulation 39
Quantitative evaluation of the Aurora inhibition effect on gene and protein expression: a mathematical modelling approach 38
A translational model-based approach to inform the choice of the dose in phase 1 oncology trials: the case study of erdafitinib 33
Combining Reinforcement Learning and PK-PD models to personalize multiple drug administration: an application to Axitinib-Anti-Hypertensive treatment in metastatic renal cancer patients 4
Totale 1.569
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.148
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.148
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020316 0 164 2 21 1 20 10 29 9 37 23 0
2020/2021183 19 17 6 20 2 21 3 29 7 26 27 6
2021/2022134 5 4 6 1 4 1 3 10 9 5 19 67
2022/2023479 52 52 4 33 49 38 1 26 194 4 11 15
2023/2024133 10 12 10 16 7 39 0 10 1 5 7 16
2024/202536 5 31 0 0 0 0 0 0 0 0 0 0
Totale 1.569